Epidemiology and characteristics of emergency departments visits by US adults with psychiatric disorder and antipsychotic mention from 2000 to 2004

Jayashri Sankaranarayanan, Susan E. Puumala

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background and objective: There is limited research to acquaint clinicians and payers about antipsychotic use in psychiatric patients visiting United States (US) emergency departments (EDs). The study objective is to describe the epidemiology and compare characteristics of ED visits by adults ≥ 18 years with psychiatric diagnoses and different types of antipsychotic. Methods: Data for 2000-2004 adult ED visits were obtained from the National Hospital Ambulatory Medical Care Survey. Sample-weighted national estimates of (1) typical, (2) atypical, or (3) typical-atypical combination antipsychotic- associated psychiatric ED visits with 95% confidence intervals (CIs) were produced. Characteristics of the three psychiatric ED visit groups with antipsychotic mention, (prescribed, supplied, administered, ordered or continued) were analyzed retrospectively. Significant characteristics for atypical versus typical antipsychotic mention at visits were determined using multivariate logistic regression. Results: Adults made an estimated 26 million ED visits over the 5-year study period that resulted in a psychiatric diagnosis. Of 2 million (or 8%) of these psychiatric ED visits, 38, 55, and 8% mentioned typical, atypical, and combination antipsychotics respectively. From 2000 to 2004 there was an 8-, 3.5-, and 1.5-fold increase in ED visits with combination, atypical, and typical antipsychotics, respectively. The majority of antipsychotic-associated psychiatric ED visits were made by young adults less than 40 years old, Caucasians, needing urgent treatment, and reimbursed by public insurance. More combination-, and typical versus atypical antipsychotic-associated ED visits included a mention of medications for extrapyramidal symptoms (40%, 14% vs. 4%; p < 0.0001) and antianxiety medications (50%, 48% vs. 27%; p < 0.0001). More combination and atypical than typical antipsychotic-related ED visits had anticonvulsant (42%, 35% vs. 12%; p < 0.0001) and antidepressant mentions (31%, 42% vs. 11%; p < 0.0001). A diagnosis of depression (OR 3.2, 95% CI: 1.9-5.3; p < 0.001) or bipolar-disorder (OR 2.5, 95% CI: 1.3-5.0; p = 0.008), and the number of medications received (OR 1.4, 95% CI: 1.0-1.8; p = 0.034) significantly increased the likelihood of atypical versus typical antipsychotic mention at psychiatric ED visits. Conclusions: Despite limitations of analyses with cross-sectional visit data, an increasing number of combination- and atypical antipsychotic-associated US adult ED visits depict the burden on the healthcare system. The associated characteristics of these visits deserve the attention of providers, and payers for cost-effective patient management.

Original languageEnglish (US)
Pages (from-to)1375-1385
Number of pages11
JournalCurrent Medical Research and Opinion
Volume23
Issue number6
DOIs
StatePublished - Jun 1 2007

Fingerprint

Antipsychotic Agents
Psychiatry
Hospital Emergency Service
Epidemiology
Confidence Intervals
Mental Disorders
Health Care Surveys
Insurance
Bipolar Disorder
Anticonvulsants
Antidepressive Agents
Young Adult
Cross-Sectional Studies
Logistic Models
Depression
Delivery of Health Care
Costs and Cost Analysis

Keywords

  • Antipsychotic
  • Atypical
  • Combination
  • Emergency department visits
  • Psychiatric disorders
  • Typical

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Epidemiology and characteristics of emergency departments visits by US adults with psychiatric disorder and antipsychotic mention from 2000 to 2004. / Sankaranarayanan, Jayashri; Puumala, Susan E.

In: Current Medical Research and Opinion, Vol. 23, No. 6, 01.06.2007, p. 1375-1385.

Research output: Contribution to journalArticle

@article{8de68140e9d44425a965da4f6112a831,
title = "Epidemiology and characteristics of emergency departments visits by US adults with psychiatric disorder and antipsychotic mention from 2000 to 2004",
abstract = "Background and objective: There is limited research to acquaint clinicians and payers about antipsychotic use in psychiatric patients visiting United States (US) emergency departments (EDs). The study objective is to describe the epidemiology and compare characteristics of ED visits by adults ≥ 18 years with psychiatric diagnoses and different types of antipsychotic. Methods: Data for 2000-2004 adult ED visits were obtained from the National Hospital Ambulatory Medical Care Survey. Sample-weighted national estimates of (1) typical, (2) atypical, or (3) typical-atypical combination antipsychotic- associated psychiatric ED visits with 95{\%} confidence intervals (CIs) were produced. Characteristics of the three psychiatric ED visit groups with antipsychotic mention, (prescribed, supplied, administered, ordered or continued) were analyzed retrospectively. Significant characteristics for atypical versus typical antipsychotic mention at visits were determined using multivariate logistic regression. Results: Adults made an estimated 26 million ED visits over the 5-year study period that resulted in a psychiatric diagnosis. Of 2 million (or 8{\%}) of these psychiatric ED visits, 38, 55, and 8{\%} mentioned typical, atypical, and combination antipsychotics respectively. From 2000 to 2004 there was an 8-, 3.5-, and 1.5-fold increase in ED visits with combination, atypical, and typical antipsychotics, respectively. The majority of antipsychotic-associated psychiatric ED visits were made by young adults less than 40 years old, Caucasians, needing urgent treatment, and reimbursed by public insurance. More combination-, and typical versus atypical antipsychotic-associated ED visits included a mention of medications for extrapyramidal symptoms (40{\%}, 14{\%} vs. 4{\%}; p < 0.0001) and antianxiety medications (50{\%}, 48{\%} vs. 27{\%}; p < 0.0001). More combination and atypical than typical antipsychotic-related ED visits had anticonvulsant (42{\%}, 35{\%} vs. 12{\%}; p < 0.0001) and antidepressant mentions (31{\%}, 42{\%} vs. 11{\%}; p < 0.0001). A diagnosis of depression (OR 3.2, 95{\%} CI: 1.9-5.3; p < 0.001) or bipolar-disorder (OR 2.5, 95{\%} CI: 1.3-5.0; p = 0.008), and the number of medications received (OR 1.4, 95{\%} CI: 1.0-1.8; p = 0.034) significantly increased the likelihood of atypical versus typical antipsychotic mention at psychiatric ED visits. Conclusions: Despite limitations of analyses with cross-sectional visit data, an increasing number of combination- and atypical antipsychotic-associated US adult ED visits depict the burden on the healthcare system. The associated characteristics of these visits deserve the attention of providers, and payers for cost-effective patient management.",
keywords = "Antipsychotic, Atypical, Combination, Emergency department visits, Psychiatric disorders, Typical",
author = "Jayashri Sankaranarayanan and Puumala, {Susan E.}",
year = "2007",
month = "6",
day = "1",
doi = "10.1185/030079907X187900",
language = "English (US)",
volume = "23",
pages = "1375--1385",
journal = "Current Medical Research and Opinion",
issn = "0300-7995",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Epidemiology and characteristics of emergency departments visits by US adults with psychiatric disorder and antipsychotic mention from 2000 to 2004

AU - Sankaranarayanan, Jayashri

AU - Puumala, Susan E.

PY - 2007/6/1

Y1 - 2007/6/1

N2 - Background and objective: There is limited research to acquaint clinicians and payers about antipsychotic use in psychiatric patients visiting United States (US) emergency departments (EDs). The study objective is to describe the epidemiology and compare characteristics of ED visits by adults ≥ 18 years with psychiatric diagnoses and different types of antipsychotic. Methods: Data for 2000-2004 adult ED visits were obtained from the National Hospital Ambulatory Medical Care Survey. Sample-weighted national estimates of (1) typical, (2) atypical, or (3) typical-atypical combination antipsychotic- associated psychiatric ED visits with 95% confidence intervals (CIs) were produced. Characteristics of the three psychiatric ED visit groups with antipsychotic mention, (prescribed, supplied, administered, ordered or continued) were analyzed retrospectively. Significant characteristics for atypical versus typical antipsychotic mention at visits were determined using multivariate logistic regression. Results: Adults made an estimated 26 million ED visits over the 5-year study period that resulted in a psychiatric diagnosis. Of 2 million (or 8%) of these psychiatric ED visits, 38, 55, and 8% mentioned typical, atypical, and combination antipsychotics respectively. From 2000 to 2004 there was an 8-, 3.5-, and 1.5-fold increase in ED visits with combination, atypical, and typical antipsychotics, respectively. The majority of antipsychotic-associated psychiatric ED visits were made by young adults less than 40 years old, Caucasians, needing urgent treatment, and reimbursed by public insurance. More combination-, and typical versus atypical antipsychotic-associated ED visits included a mention of medications for extrapyramidal symptoms (40%, 14% vs. 4%; p < 0.0001) and antianxiety medications (50%, 48% vs. 27%; p < 0.0001). More combination and atypical than typical antipsychotic-related ED visits had anticonvulsant (42%, 35% vs. 12%; p < 0.0001) and antidepressant mentions (31%, 42% vs. 11%; p < 0.0001). A diagnosis of depression (OR 3.2, 95% CI: 1.9-5.3; p < 0.001) or bipolar-disorder (OR 2.5, 95% CI: 1.3-5.0; p = 0.008), and the number of medications received (OR 1.4, 95% CI: 1.0-1.8; p = 0.034) significantly increased the likelihood of atypical versus typical antipsychotic mention at psychiatric ED visits. Conclusions: Despite limitations of analyses with cross-sectional visit data, an increasing number of combination- and atypical antipsychotic-associated US adult ED visits depict the burden on the healthcare system. The associated characteristics of these visits deserve the attention of providers, and payers for cost-effective patient management.

AB - Background and objective: There is limited research to acquaint clinicians and payers about antipsychotic use in psychiatric patients visiting United States (US) emergency departments (EDs). The study objective is to describe the epidemiology and compare characteristics of ED visits by adults ≥ 18 years with psychiatric diagnoses and different types of antipsychotic. Methods: Data for 2000-2004 adult ED visits were obtained from the National Hospital Ambulatory Medical Care Survey. Sample-weighted national estimates of (1) typical, (2) atypical, or (3) typical-atypical combination antipsychotic- associated psychiatric ED visits with 95% confidence intervals (CIs) were produced. Characteristics of the three psychiatric ED visit groups with antipsychotic mention, (prescribed, supplied, administered, ordered or continued) were analyzed retrospectively. Significant characteristics for atypical versus typical antipsychotic mention at visits were determined using multivariate logistic regression. Results: Adults made an estimated 26 million ED visits over the 5-year study period that resulted in a psychiatric diagnosis. Of 2 million (or 8%) of these psychiatric ED visits, 38, 55, and 8% mentioned typical, atypical, and combination antipsychotics respectively. From 2000 to 2004 there was an 8-, 3.5-, and 1.5-fold increase in ED visits with combination, atypical, and typical antipsychotics, respectively. The majority of antipsychotic-associated psychiatric ED visits were made by young adults less than 40 years old, Caucasians, needing urgent treatment, and reimbursed by public insurance. More combination-, and typical versus atypical antipsychotic-associated ED visits included a mention of medications for extrapyramidal symptoms (40%, 14% vs. 4%; p < 0.0001) and antianxiety medications (50%, 48% vs. 27%; p < 0.0001). More combination and atypical than typical antipsychotic-related ED visits had anticonvulsant (42%, 35% vs. 12%; p < 0.0001) and antidepressant mentions (31%, 42% vs. 11%; p < 0.0001). A diagnosis of depression (OR 3.2, 95% CI: 1.9-5.3; p < 0.001) or bipolar-disorder (OR 2.5, 95% CI: 1.3-5.0; p = 0.008), and the number of medications received (OR 1.4, 95% CI: 1.0-1.8; p = 0.034) significantly increased the likelihood of atypical versus typical antipsychotic mention at psychiatric ED visits. Conclusions: Despite limitations of analyses with cross-sectional visit data, an increasing number of combination- and atypical antipsychotic-associated US adult ED visits depict the burden on the healthcare system. The associated characteristics of these visits deserve the attention of providers, and payers for cost-effective patient management.

KW - Antipsychotic

KW - Atypical

KW - Combination

KW - Emergency department visits

KW - Psychiatric disorders

KW - Typical

UR - http://www.scopus.com/inward/record.url?scp=34347223236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34347223236&partnerID=8YFLogxK

U2 - 10.1185/030079907X187900

DO - 10.1185/030079907X187900

M3 - Article

C2 - 17594776

AN - SCOPUS:34347223236

VL - 23

SP - 1375

EP - 1385

JO - Current Medical Research and Opinion

JF - Current Medical Research and Opinion

SN - 0300-7995

IS - 6

ER -